{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:45:31Z","timestamp":1790646331515,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/K000608\/1"],"award-info":[{"award-number":["MR\/K000608\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"NINDS","doi-asserted-by":"publisher","award":["1U54NS065712-01"],"award-info":[{"award-number":["1U54NS065712-01"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Department of Health's National Institute"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.nmd.2015.02.001","type":"journal-article","created":{"date-parts":[[2015,2,13]],"date-time":"2015-02-13T23:35:57Z","timestamp":1423870557000},"page":"511-515","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Transthyretin V122I amyloidosis with clinical and histological evidence of amyloid neuropathy and myopathy"],"prefix":"10.1016","volume":"25","author":[{"given":"A.S.","family":"Carr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.L.","family":"Pelayo-Negro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Jaunmuktane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.S.","family":"Scalco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3466-306X","authenticated-orcid":false,"given":"D.","family":"Hutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.R.B.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Heally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Brandner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Holton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Blake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.J.","family":"Whelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.D.","family":"Wechalekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.D.","family":"Gillmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.N.","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.M.","family":"Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2015.02.001_bib0010","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJM199709253371306","article-title":"The systemic amyloidosis","volume":"337","author":"Falk","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nmd.2015.02.001_bib0015","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1258\/acb.2011.011225","article-title":"Amyloidosis","volume":"49","author":"Pinney","year":"2012","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.nmd.2015.02.001_bib0020","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1182\/blood.V79.7.1817.1817","article-title":"Incidence and natural history of primary systemic amyloidosis in Olmstead County, Minnesota, 1950 through 1989","volume":"79","author":"Kyle","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.nmd.2015.02.001_bib0025","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/bjh.12286","article-title":"Systemic amyloidosis in England: an epidemiological study","volume":"161","author":"Pinney","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.nmd.2015.02.001_bib0030","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0025-6196(12)64885-X","article-title":"Pathology of the senescent heart: anatomic observations on 237 autopsy studies of patient 95\u2013105 years old","volume":"63","author":"Lie","year":"1998","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.nmd.2015.02.001_bib0035","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3109\/13506120308998998","article-title":"Tabulation of human tranthyretin (TTR) variants, 2003","volume":"10","author":"Connors","year":"2003","journal-title":"Amyloid"},{"key":"10.1016\/j.nmd.2015.02.001_bib0040","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/eurheartj\/ehs123","article-title":"Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective","volume":"34","author":"Rapezzi","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.nmd.2015.02.001_bib0045","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1212\/WNL.58.7.1001","article-title":"Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity","volume":"58","author":"Ikeda","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2015.02.001_bib0050","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1365-2796.2003.01173.x","article-title":"Hereditary transthyretin amyloidosis from a Scandinavian perspective","volume":"254","author":"Suhr","year":"2003","journal-title":"J Intern Med"},{"key":"10.1016\/j.nmd.2015.02.001_bib0055","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1468-1331.2004.00941.x","article-title":"Phenotypic expression of familial amyloid polyneuropathy in Brazil","volume":"12","author":"Bittencourt","year":"2005","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nmd.2015.02.001_bib0060","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/mus.20644","article-title":"Clinical variability in type 1 familial amyloid polyneuropathy (Val30Met): comparison between late- and early-onset cases in Portugal","volume":"35","author":"Conceicao","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2015.02.001_bib0065","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1750-1172-8-31","article-title":"Guideline of transthyretin-related hereditary amyloidosis for clinicians","volume":"8","author":"Ando","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.nmd.2015.02.001_bib0070","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/01.TP.0000092307.98347.CB","article-title":"Ten years of international experience with liver transplant for familial amyloid polyneuropathy: results from the Familial Amyloidotic Polyneuropathy World Transplant Registry","volume":"77","author":"Herlenius","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.nmd.2015.02.001_bib0075","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00109-010-0695-1","article-title":"Variation in amount of wild-type transthyretin in different fibril and tissue types in ATTR amyloidosis","volume":"89","author":"Ihse","year":"2011","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.nmd.2015.02.001_bib0080","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/eurheartj\/ehr383","article-title":"Cardiac phenotype and clinical outcome of familial amyloid polyneuropathy associated with transthyretin alanine 60 variant","volume":"33","author":"Sattianayagam","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.nmd.2015.02.001_bib0085","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1056\/NEJM199702133360703","article-title":"Variant sequence transthyretin (isoleicine 122) in late-onset cardiac amyloidosis in black Americans","volume":"336","author":"Jacobson","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nmd.2015.02.001_bib0090","first-page":"45","article-title":"Transthyretin Ile 122 and cardiac amyloidosis in African-Americans: 2 case reports","volume":"24","author":"Jacobson","year":"1997","journal-title":"Tex Heart Inst J"},{"key":"10.1016\/j.nmd.2015.02.001_bib0095","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/j.1600-6143.2008.02162.x","article-title":"Heart transplantation for homozygous familial transthyretin (TTR) V122I cardiac amyloidosis","volume":"8","author":"Hamour","year":"2008","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.nmd.2015.02.001_bib0100","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/13506129.2012.666509","article-title":"The first Caucasian patient with p.Val122Ile mutated-transthyretin cardiac amyloidosis treated with isolated heart transplantation","volume":"19","author":"Ammirati","year":"2012","journal-title":"Amyloid"},{"key":"10.1016\/j.nmd.2015.02.001_bib0105","first-page":"175","article-title":"Senile cardiac amyloidosis associated with homozygosity for a transthyretin variant (ILE-122)","volume":"117","author":"Nichols","year":"1991","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.nmd.2015.02.001_bib0110","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ahj.2012.04.013","article-title":"The electrodiagnostic features associated with cardiac amyloidosis of variant transthyretin isoleucine 122 type in Afro-Caribbean patients","volume":"164","author":"Dungu","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.nmd.2015.02.001_bib0115","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1136\/jnnp-2013-305383","article-title":"Overcoming artefact: anticipation in 284 Portuguese kindreds with familial amyloid polyneuropathy (FAP) ATTRV30M","volume":"85","author":"Lemos","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2015.02.001_bib0120","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ahj.2009.08.006","article-title":"Cardiac amyloidosis in African Americans: comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosis","volume":"158","author":"Connors","year":"2009","journal-title":"Am Heart J"},{"issue":"9","key":"10.1016\/j.nmd.2015.02.001_bib0125","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.3346\/jkms.2013.28.9.1323","article-title":"Complication rate of transfemoral endomyocardial biopsy with fluoroscopic and two-dimensional echocardiographic guidance: a 10-year experience of 228 consecutive procedures","volume":"28","author":"Jang","year":"2013","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.nmd.2015.02.001_bib0130","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1161\/CIRCULATIONAHA.107.743427","article-title":"Complication rate of right ventricular endomyocardial biopsy via the femoral approach. a retrospective and prospective study analyzing 3048 diagnostic procedures over an 11-year period","volume":"118","author":"Holzmann","year":"2008","journal-title":"Circulation"},{"issue":"78","key":"10.1016\/j.nmd.2015.02.001_bib0135","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1212\/WNL.0b013e318248df18","article-title":"Long-term survival after liver transplantation in patients with familial amyloid polyneuropathy","volume":"28","author":"Yamashita","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2015.02.001_bib0140","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1093\/brain\/123.7.1495","article-title":"The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation","volume":"123","author":"Adams","year":"2000","journal-title":"Brain"},{"issue":"Suppl. 1","key":"10.1016\/j.nmd.2015.02.001_bib0145","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3109\/13506129.2012.678509","article-title":"The Diflunasil Trial: study accrual and drug tolerance","volume":"19","author":"Berk","year":"2012","journal-title":"Amyloid"},{"issue":"24","key":"10.1016\/j.nmd.2015.02.001_bib0150","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1001\/jama.2013.283815","article-title":"Repurposing diflunisal for familial amyloid polyneuropathya randomized clinical trial","volume":"310","author":"Berk","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.nmd.2015.02.001_bib0155","series-title":"Safety and efficacy of tafamidis in patients with transthyretin cardiomyopathy (ATTR-ACT) ClinicalTrials.gov Identifier: NCT01994889","author":"Pfizer","year":"2015"},{"key":"10.1016\/j.nmd.2015.02.001_bib0160","series-title":"Phase 2 study to evaluate ALN-TTRSC in patients with transthyretin (TTR) Cardiac Amyloidosis ClinicalTrials.gov Identifier: NCT01981837","author":"Alnylam Pharmaceuticals","year":"2015"},{"issue":"3","key":"10.1016\/j.nmd.2015.02.001_bib0165","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s11910-013-0435-3","article-title":"FAP neuropathy and emerging treatments","volume":"14","author":"Adams","year":"2014","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.nmd.2015.02.001_bib0170","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jmoldx.2013.08.001","article-title":"Homozygosity for the V122I mutation in transthyretin is associated with earlier onset of cardiac amyloidosis in the African American population in the seventh decade","volume":"16","author":"Reddi","year":"2013","journal-title":"J Mol Diagn"},{"issue":"11","key":"10.1016\/j.nmd.2015.02.001_bib0175","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/ehjci\/jeu107","article-title":"Utility and limitations of 3,3-diphosphono-1\u20132-propanodycarboxylic acid scintigraphy in systemic amyloidosis","volume":"15","author":"Hutt","year":"2014","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"6","key":"10.1016\/j.nmd.2015.02.001_bib0180","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2005.05.073","article-title":"Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-Diphosphono-1,2-Propanodicarboxylic acid scintigraphy","volume":"46","author":"Perugini","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nmd.2015.02.001_bib0185","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1007\/s00259-008-1037-1","article-title":"Nuclear imaging in cardiac amyloidosis","volume":"36","author":"Glaudemans","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096089661500036X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096089661500036X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:03:19Z","timestamp":1760774599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096089661500036X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S096089661500036X"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2015.02.001","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transthyretin V122I amyloidosis with clinical and histological evidence of amyloid neuropathy and myopathy","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2015.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}